Search research articles
Contact Us
Filters
Showing results (151-160 of 214) with videos related to
Page
of 22
Sort By:
British Journal of Haematology
|
June 29, 2006
Validation of the European Prognostic Index for younger adult patients with acute myeloid leukaemia in first relapse
Francis Giles, Srdan Verstovsek, Guillermo Garcia-Manero, et al.
American Journal of Hematology
|
November 6, 2018
Recommendations for the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia: A consensus of North American experts
Nicholas J Short, Elias Jabbour, Maher Albitar, et al.
British Journal of Haematology
|
January 17, 2007
The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia
Francis J Giles, Gautam Borthakur, Farhad Ravandi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 22, 2009
Proteasome enzymatic activities in plasma as risk stratification of patients with acute myeloid leukemia and advanced-stage myelodysplastic syndrome
Wanlong Ma, Hagop Kantarjian, Benjamin Bekele, et al.
Blood
|
July 20, 2002
Myelodysplastic syndrome is not merely "preleukemia"
Maher Albitar, Taghi Manshouri, Yu Shen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2006
A phase I study of intravenous LBH589, a novel cinnamic hydroxamic acid analogue histone deacetylase inhibitor, in patients with refractory hematologic malignancies
Francis Giles, Thomas Fischer, Jorge Cortes, et al.
Blood
|
May 3, 2002
Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase
Hagop M Kantarjian, Jorge Cortes, Susan O'Brien, et al.
British Journal of Haematology
|
May 20, 2003
A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expression
Francis J Giles, B Nebiyou Bekele, Susan O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 2009
Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial
David P Steensma, Maria R Baer, James L Slack, et al.
Frontiers in Oncology
|
March 31, 2025
Next-generation sequencing guides diagnosis and treatment in a complex presentation of ALK-positive anaplastic large-cell lymphoma: a case report
Tejasvini Vaid, Thomas S Gunning, Rachel Cohen, et al.
Page
of 22
Search research articles
Search
Showing results (151-160 of 214) with videos related to
Sort By:
Page
of 22
British Journal of Haematology
|
June 29, 2006
Validation of the European Prognostic Index for younger adult patients with acute myeloid leukaemia in first relapse
Francis Giles, Srdan Verstovsek, Guillermo Garcia-Manero, et al.
American Journal of Hematology
|
November 6, 2018
Recommendations for the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia: A consensus of North American experts
Nicholas J Short, Elias Jabbour, Maher Albitar, et al.
British Journal of Haematology
|
January 17, 2007
The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia
Francis J Giles, Gautam Borthakur, Farhad Ravandi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 22, 2009
Proteasome enzymatic activities in plasma as risk stratification of patients with acute myeloid leukemia and advanced-stage myelodysplastic syndrome
Wanlong Ma, Hagop Kantarjian, Benjamin Bekele, et al.
Blood
|
July 20, 2002
Myelodysplastic syndrome is not merely "preleukemia"
Maher Albitar, Taghi Manshouri, Yu Shen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2006
A phase I study of intravenous LBH589, a novel cinnamic hydroxamic acid analogue histone deacetylase inhibitor, in patients with refractory hematologic malignancies
Francis Giles, Thomas Fischer, Jorge Cortes, et al.
Blood
|
May 3, 2002
Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase
Hagop M Kantarjian, Jorge Cortes, Susan O'Brien, et al.
British Journal of Haematology
|
May 20, 2003
A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expression
Francis J Giles, B Nebiyou Bekele, Susan O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 2009
Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial
David P Steensma, Maria R Baer, James L Slack, et al.
Frontiers in Oncology
|
March 31, 2025
Next-generation sequencing guides diagnosis and treatment in a complex presentation of ALK-positive anaplastic large-cell lymphoma: a case report
Tejasvini Vaid, Thomas S Gunning, Rachel Cohen, et al.
Page
of 22